Projects funded by the NCN
Quantitative assessment of vascular endothelial growth factor (VEGF) in serum, follicular fluid (FF) and VEGF mRNA in granulosa cells (GS) as risk factors of ovarian hyperstimulation syndrome (OHSS) occurrence in controlled ovarian hyperstimulation protocols (COH) which use gonadotropin-releasing hormone (GnRH) antagonists or agonists, and in natural cycle oocyte retrieval protocol.
2011/01/B/NZ5/05373
Keywords:
ovarian hyperstimulation syndrome (OHSS) vascular endothelial growth factor (VEGF) mRNA VEGF mRNA EG-VEGF Prokinectin 1 S VEGFr1/FLT1,controlled ovarian hyperstimulation protocols (COH) human chorionic gonadotropin (hCG) gonadotropin-releasing hormone (GnRH),GnRH antagonist GnRH agonist
Descriptors:
- NZ5_5: Diagnostics in human diseases
Panel:
NZ5 - Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)
Host institution :
Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN
woj. mazowieckie
Principal investigator (from the host institution):
Number of co-investigators in the project: 7
Call: OPUS 1 - announced on 2011-03-15
Amount awarded: 597 155 PLN
Project start date (Y-m-d): 2011-12-08
Project end date (Y-m-d): 2015-12-07
Project duration:: 48 months (the same as in the proposal)
Project status: Project settled